SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific informs about press release

16 Dec 2021 Evaluate
Sequent Scientific has informed that Evance Saude Animal Health a ('Evance'), Brazil, a subsidiary of the Company has entered into a definitive agreement for acquisition of 100% stake in Nourrie Saúde e Nutrição Animal a('Nourrie'). In this regard, it attached: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; A Press Release issued by the Company along with an Investor Presentation on the proposed acquisition

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

294.60 6.50 (2.26%)
02-Jul-2026 11:42 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.95
Dr. Reddys Labs. 1349.20
Cipla 1459.65
Zydus Lifesciences 1099.00
Lupin 2390.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: